Triana Biomedicines

About:

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Website: https://trianabio.com

Top Investors: RA Capital Management, Lightspeed Venture Partners, Atlas Venture, Surveyor Capital, Logos Capital

Description:

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated the best-in-class platform and initiated multiple programs across different disease areas.

Total Funding Amount:

$161M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2019-01-01

Founders:

Jesse Chen, Milind Deshpande, Simon Read

Number of Employees:

11-50

Last Funding Date:

2022-04-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai